Journal article
Minimally invasive management of upper tract urothelial carcinoma
Current urology reports, Vol.7(1), pp.23-30
01/2006
DOI: 10.1007/s11934-006-0034-9
PMID: 16480665
Abstract
Recently published studies that evaluated minimally invasive treatments for upper tract urothelial cancer (UTUC) were reviewed, including adjuvant topical therapy. Ureteroscopic management remains the initial diagnostic and possibly therapeutic procedure of choice. Percutaneous management is used to treat bulky tumors or tumors that cannot be accessed ureteroscopically. Low-grade UTUC in appropriately selected patients can be safely and effectively treated endoscopically. High-grade disease tends to fail, regardless of treatment modality, and warrants aggressive therapy. Adjuvant therapy seems to be safe, although its efficacy is debatable. Immunotherapy appears to be most effective in patients with upper tract carcinoma in situ.
Details
- Title: Subtitle
- Minimally invasive management of upper tract urothelial carcinoma
- Creators
- Fadi N Joudi - Department of Urology, University of Iowa, IA 52242-1089, USACurtis N CraneMichael A O'Donnell
- Resource Type
- Journal article
- Publication Details
- Current urology reports, Vol.7(1), pp.23-30
- Publisher
- United States
- DOI
- 10.1007/s11934-006-0034-9
- PMID
- 16480665
- ISSN
- 1527-2737
- eISSN
- 1534-6285
- Language
- English
- Date published
- 01/2006
- Academic Unit
- Urology
- Record Identifier
- 9984051719502771
Metrics
17 Record Views